Safety Profile and Effectiveness of Rivaroxaban for Patients With Venous Thromboembolism in Japan ― Results From Post-Marketing Surveillance (XASSENT) ―Ikuo Fukuda, Takanori Hayasaki, Kazuo Kawasugi et al.|Circulation Journal|2023Cited by 3